BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ActiMaris - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ActiMaris
X-ORIGINAL-URL:https://www.actimaris.com/?lang=en
X-WR-CALDESC:Events for ActiMaris
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250410
DTEND;VALUE=DATE:20250412
DTSTAMP:20260423T205817
CREATED:20250228T113115Z
LAST-MODIFIED:20250228T113141Z
UID:11482-1744243200-1744415999@www.actimaris.com
SUMMARY:16th Abu Dhabi Wound Care conference 2025
DESCRIPTION:ActiMaris® at the 16th Abu Dhabi Wound Care Conference 2025 – Scientific Presentation on Wound Treatment\nNew Insights into the Correlation Between In-Vitro and In-Vivo Efficacy of Antimicrobial Wound Therapies\nConference Highlights:\n\nKeynote lectures by international wound care experts\nLatest research in wound management and antimicrobial therapies\nPresentation of cutting-edge innovations in wound care\nNetworking opportunities with industry leaders\n\nProgram\nMore informationDOES THE IN VITRO EFFICACY PROMISE CORRELATE WITH THE IN VIVO REALITY AND CLINICAL EFFECTIVENESS IN THE LOCAL WOUND TREATMENT WITH ANTIMICROBIALS?\nOur Presentation:\nActiMaris AG will present groundbreaking research on the effectiveness of the HOCl/NaOCl Redox Complex compared to other antimicrobial wound products. The study explores whether in-vitro antimicrobial efficacy truly translates into clinical performance in wound treatment. \n\n\n    \n        \n\n    \n\nAutor: Damir Marincic MD\, Quorum Medis Institute\, St.Gallen\, SWITZERLAND \nAim:\nEffective wound care products should demonstrate strong antimicrobial effects\, biofilm disruption\, anti-inflammatory action\, and low cytotoxicity\, often assessed via a biocompatibility index in vitro. However\, in vitro tests approximate clinical conditions and may not reflect clinical outcomes. This study examines the correlation between in vitro efficacy and in vivo effectiveness across various antimicrobials. \nMethod:\nFour in vitro studies were conducted on 15 antimicrobials (4 PHMB\, 1 Octenidine\, 1 PVP-I\, and 9 HOCl/NaOCl products)\, including HOCl/NaOCl redox complex*. Concentrations and physicochemical properties varied among the tested products. In vivo\, two clinical studies involving over 400 patients evaluated eight products (2 PHMB\, 1 Octenidine\, and 5 HOCl/NaOCl) for their antimicrobial efficacy directly in wounds. \nResults / Discussion:\nIn vitro\, HOCl/NaOCl products showed varied efficacy\, dependent on concentration and physicochemical parameters. Products with 100–300 ppm demonstrated limited efficacy (log10 reduction of 1.5–3.0)\, whereas those with 400–800 ppm exhibited stronger efficacy (up to 5 log10) but with a slower onset (≥10 minutes). The HOCl/NaOCl redox complex* at 2000 ppm showed the highest efficacy of 6.2–7.2 log10 with a rapid onset (<1 minute)\, in vivo 3.4 log10 level. Other products with 100–800 ppm had lower antimicrobial efficacy (≤2.0 log10)\, comparable to polyhexanide product. \nConclusion:\nMost products failed to translate in vitro antimicrobial results into in vivo performance. Efficacy depends not only on active substance concentration but also on specific physicochemical and colligative properties. The HOCl/NaOCl redox complex* consistently demonstrated superior efficacy both in vitro and in clinical settings\, maintaining its promise in practical use. \n*ActiMaris complex
URL:https://www.actimaris.com/event/16th-abu-dhabi-wound-care-conference-2025-2/?lang=en
ATTACH;FMTTYPE=image/jpeg:https://www.actimaris.com/wp-content/uploads/2025/02/NEW-16th-Abu-Dhabi-Wound-Care-Conference.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20230510T080000
DTEND;TZID=Europe/Zurich:20230512T170000
DTSTAMP:20260423T205817
CREATED:20230322T083813Z
LAST-MODIFIED:20230322T084057Z
UID:11096-1683705600-1683910800@www.actimaris.com
SUMMARY:DEWU German Wound Congress & Bremen Nursing Congress 2023
DESCRIPTION:ActiMaris® at German Wound Congress & Bremen Nursing Congress 2023\nThe largest German forum on the topic of chronic wounds.\n  \nradio_button_uncheckedActiMaris AG is pleased to announce that together with our valued partner Chemomedica Medizintechnik und Arzneimittel Vertriebsges.m.b.H. we will be attending the prestigious DEWU German Wound Congress 2023 in Bremen. The congress\, which will take place from May 10-12\, 2023\, is a major event that brings together professionals in the field of wound care and research to share knowledge and learn about new technologies and treatments. \nOur participation in the DEWU German Wound Congress 2023 underscores our commitment to the ongoing improvement of patient care and the development of innovative solutions in the field of wound care. We look forward to sharing our experience and insights with industry peers while benefiting from the latest developments and research. \nWe invite you to visit us during the congress at our joint booth with Chemomedica Medizintechnik und Arzneimittel Vertriebsges.m.b.H.. There you will have the opportunity to get to know our latest products and solutions and to exchange ideas with our experts about the current challenges and opportunities in wound care. \nWe look forward to your participation and a fruitful exchange at the DEWU German Wound Congress 2023 in Bremen. Until then\, we wish you every success and look forward to a successful cooperation! \nProgram\nProgramMore information here
URL:https://www.actimaris.com/event/dewu-german-wound-congress-bremen-nursing-congress-2023/?lang=en
LOCATION:Messe Bremen\, Findorffstraße 101\, Bremen\, 28215\, Deutschland
CATEGORIES:wound congress
ATTACH;FMTTYPE=image/png:https://www.actimaris.com/wp-content/uploads/2023/03/Bildschirmfoto-2023-03-22-um-09.21.16.png
ORGANIZER;CN="DEWU German Wound Congress":MAILTO:service@pflege-wundkongress.de
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20230503T093000
DTEND;TZID=Europe/Zurich:20230505T170000
DTSTAMP:20260423T205817
CREATED:20230206T094555Z
LAST-MODIFIED:20230216T131057Z
UID:10904-1683106200-1683306000@www.actimaris.com
SUMMARY:EWMA 2023
DESCRIPTION:ActiMaris® at EWMA 2023 \nTHE 33RD CONFERENCE OF THE EUROPEAN WOUND MANAGEMENT ASSOCIATION\n  \nradio_button_uncheckedActiMaris AG is pleased to participate with an active contribution at the Wound Congress EWMA 2023 in Milan\, Italy. We are happy to share our latest research results with interested professionals who are looking for new therapeutic options. Our company aims to find new ways to improve the treatment of chronic wounds. We believe that this congress is a valuable opportunity to share our ideas and findings with the professional community. You are welcome to visit us at the congress at our booth. We look forward to seeing you. \nProgram\nProgramMore information here
URL:https://www.actimaris.com/event/ewma-2023/?lang=en
LOCATION:MICo Milano Convention Center\, Piazzale Carlo Magno\, Milan\, 20149\, Italien
CATEGORIES:wound congress
ATTACH;FMTTYPE=image/png:https://www.actimaris.com/wp-content/uploads/2023/02/03_412723_EWMA_webbanner_1200x540px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250410
DTEND;VALUE=DATE:20250412
DTSTAMP:20260423T205817
CREATED:20250224T131522Z
LAST-MODIFIED:20250228T110737Z
UID:11438-1744243200-1744415999@www.actimaris.com
SUMMARY:16th Abu Dhabi Wound Care conference 2025
DESCRIPTION:ActiMaris® at the 16th Abu Dhabi Wound Care Conference 2025 – Scientific Presentation on Wound Treatment\nNew Insights into the Correlation Between In-Vitro and In-Vivo Efficacy of Antimicrobial Wound Therapies\nConference Highlights:\n\nKeynote lectures by international wound care experts\nLatest research in wound management and antimicrobial therapies\nPresentation of cutting-edge innovations in wound care\nNetworking opportunities with industry leaders\n\nProgram\nMore informationDOES THE IN VITRO EFFICACY PROMISE CORRELATE WITH THE IN VIVO REALITY AND CLINICAL EFFECTIVENESS IN THE LOCAL WOUND TREATMENT WITH ANTIMICROBIALS?\nOur Presentation:\nActiMaris AG will present groundbreaking research on the effectiveness of the HOCl/NaOCl Redox Complex compared to other antimicrobial wound products. The study explores whether in-vitro antimicrobial efficacy truly translates into clinical performance in wound treatment. \n\n\n    \n        \n\n    \n\nAutor: Damir Marincic MD\, Quorum Medis Institute\, St.Gallen\, SWITZERLAND \nAim:\nEffective wound care products should demonstrate strong antimicrobial effects\, biofilm disruption\, anti-inflammatory action\, and low cytotoxicity\, often assessed via a biocompatibility index in vitro. However\, in vitro tests approximate clinical conditions and may not reflect clinical outcomes. This study examines the correlation between in vitro efficacy and in vivo effectiveness across various antimicrobials. \nMethod:\nFour in vitro studies were conducted on 15 antimicrobials (4 PHMB\, 1 Octenidine\, 1 PVP-I\, and 9 HOCl/NaOCl products)\, including HOCl/NaOCl redox complex*. Concentrations and physicochemical properties varied among the tested products. In vivo\, two clinical studies involving over 400 patients evaluated eight products (2 PHMB\, 1 Octenidine\, and 5 HOCl/NaOCl) for their antimicrobial efficacy directly in wounds. \nResults / Discussion:\nIn vitro\, HOCl/NaOCl products showed varied efficacy\, dependent on concentration and physicochemical parameters. Products with 100–300 ppm demonstrated limited efficacy (log10 reduction of 1.5–3.0)\, whereas those with 400–800 ppm exhibited stronger efficacy (up to 5 log10) but with a slower onset (≥10 minutes). The HOCl/NaOCl redox complex* at 2000 ppm showed the highest efficacy of 6.2–7.2 log10 with a rapid onset (<1 minute)\, in vivo 3.4 log10 level. Other products with 100–800 ppm had lower antimicrobial efficacy (≤2.0 log10)\, comparable to polyhexanide product. \nConclusion:\nMost products failed to translate in vitro antimicrobial results into in vivo performance. Efficacy depends not only on active substance concentration but also on specific physicochemical and colligative properties. The HOCl/NaOCl redox complex* consistently demonstrated superior efficacy both in vitro and in clinical settings\, maintaining its promise in practical use. \n*ActiMaris complex
URL:https://www.actimaris.com/event/16th-abu-dhabi-wound-care-conference-2025/?lang=en
LOCATION:Abu Dhabi National Exhibition Centre (ADNEC)\, Capital tower ADNEC Area\, Abu Dhabi\, United Arab Emirates
CATEGORIES:wound congress
ATTACH;FMTTYPE=image/jpeg:https://www.actimaris.com/wp-content/uploads/2025/02/NEW-16th-Abu-Dhabi-Wound-Care-Conference.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20230202T000000
DTEND;TZID=Europe/Zurich:20230204T000000
DTSTAMP:20260423T205817
CREATED:20230223T192101Z
LAST-MODIFIED:20230223T192502Z
UID:10986-1675296000-1675468800@www.actimaris.com
SUMMARY:Healing Hands Conference 2023
DESCRIPTION:ActiMaris® at Healing Hands Conference 2023\nComplex Wounds Event Kuwait\n  \nradio_button_uncheckedActiMaris AG with distributor SwissTech International at the Healing Hands Conference 2023 in Kuwait. \n  \n  \n	\n		\n							\n								\n			\n	\n		\n							\n								\n			\n	\n		\n							\n								\n			\n	\n		\n			\n		\n	\n		\n	Program\nMore information here
URL:https://www.actimaris.com/event/healing-hands-conference-2023/?lang=en
LOCATION:Jumeirah beach Hotel\, Messila ballroom\, Kuwait\, Kuwait
CATEGORIES:wound congress
ATTACH;FMTTYPE=image/png:https://www.actimaris.com/wp-content/uploads/2023/02/Bildschirmfoto-2023-02-23-um-20.11.12.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20210428T083000
DTEND;TZID=Europe/Zurich:20210430T173000
DTSTAMP:20260423T205817
CREATED:20200921T140827Z
LAST-MODIFIED:20201104T151321Z
UID:9582-1619598600-1619803800@www.actimaris.com
SUMMARY:3-day anniversary wound congress
DESCRIPTION:ActiMaris® at “20 years ZWM®-CertifiedWundManagement” \n3-day anniversary wound congress\nradio_button_uncheckedBased on the current COV-19 development in German-speaking Europe\, the 35th Wound Congress was postponed from 21-23.10.2020 to 28-30.04.2021 \nProgram\nMore information here
URL:https://www.actimaris.com/event/wuwhs-2020-2/?lang=en
LOCATION:Hotel Wyndham in Salzburg\, Fanny-von-Lehnert-Straße 7\, Salzburg\, 5020\, Österreich
CATEGORIES:wound congress
ATTACH;FMTTYPE=image/jpeg:https://www.actimaris.com/wp-content/uploads/2020/09/Kongress_Programm_Salzburg_2020-1_Titelbild.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20200206T090000
DTEND;TZID=Europe/Zurich:20200206T163000
DTSTAMP:20260423T205817
CREATED:20200123T075836Z
LAST-MODIFIED:20200123T075836Z
UID:8936-1580979600-1581006600@www.actimaris.com
SUMMARY:15. Wound Specialist Day
DESCRIPTION:gd medical ag at 15. Wound Specialist Day\nradio_button_uncheckedThe 15th Wound Specialist Day will take place on 6 February 2020 at the University Hospital Zurich.\nWe are delighted that our distributor gd medical ag will be attending this event. \nWatch the program
URL:https://www.actimaris.com/event/swiss-intermediate-care-symposium/?lang=en
LOCATION:Universitätsspital Zürich\, Frauenklinikstrasse 10\, Zürich\, Zürich\, 8091\, Schweiz
CATEGORIES:Wound Specialist Day
ATTACH;FMTTYPE=image/jpeg:https://www.actimaris.com/wp-content/uploads/2020/01/titelbild_atypische_wunden.jpeg__6000x4000_q85_subsampling-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20200124T100000
DTEND;TZID=Europe/Zurich:20200124T173000
DTSTAMP:20260423T205817
CREATED:20200106T103630Z
LAST-MODIFIED:20200123T075601Z
UID:8931-1579860000-1579887000@www.actimaris.com
SUMMARY:Swiss Intermediate Care Symposium
DESCRIPTION:gd medical ag at the 1st Swiss Intermediate Care Symposium\nradio_button_uncheckedThe 1st Swiss Intermediate Care Symposium will take place on 24 January 2020 at the Inselspital in Berne.\nWe are delighted that our distributor gd medical ag will be attending this event. \nThe main theme of the interdisciplinary and interprofessional symposium is” IMC – a future-oriented department ”\nIn keeping with the motto\, the plenary sessions are interdisciplinary and deal with specific topics from our everyday professional lives: delirium\, the geriatric patient\, ethical aspects and anticoagulation. Parallel to this\, hands-on workshops on non-invasive ventilation and tracheal cannulae\, ECG\, pain therapy and delir as well as a BLS Refresher Course will be offered. \nWatch the program
URL:https://www.actimaris.com/event/swiss-intermediate-care-symposium-2/?lang=en
LOCATION:Inselspital Bern\, Freiburgstrasse 15a\, Bern\, Bern\, 9010\, Schweiz
CATEGORIES:Symposium
ATTACH;FMTTYPE=image/jpeg:https://www.actimaris.com/wp-content/uploads/2020/04/IMICSY20_HomepageBanner_04_DE.jpg
ORGANIZER;CN="IMK":MAILTO:congress@imk.ch
END:VEVENT
END:VCALENDAR